The difference between information and
expert, data-driven actionable intelligence

 

September 2017

Welcome to the September 2017 issue of CMC Market Outlook

This monthly e-newsletter provides valuable insights for both buyers and sellers of CMC drug development services. Our coverage will help you identify and understand market trends that will inform your strategic business perspective.

Enjoy the September issue!

The PharmSource Team

Flexibility and Innovation Needed to Solve Manufacturing Uncertainity

by Jim Miller, President, PharmSource

Matching the production requirements of a bio/pharma company with the manufacturing capabilities of a CMO is a delicate balance, requiring attitude shifts on both sides of the table.

The need for flexibility in manufacturing arrangements and technologies has never been greater. New products…… read on


Sizeable South African Market Attracts, Challenges Pharma Industry Investment

by Lisa Tilley Hinkle and Renee Richmond

South Africa’s pharmaceutical market, the largest and most developed in Sub-Saharan Africa, is expanding at a good clip, making it attractive to drug makers seeking a foothold in the broader African region. Those opportunities are challenged by such factors as intellectual property issues, regulatory inconsistency, remoteness from other global markets and relatively low per capital expenditure on pharma products.

However, a new regulatory agency and recently proposed new intellectual property policies may help to smooth over some obstacles over time……read on



Dose CMOs Stuck in Idle

 

PharmSource’s just-released trend report, Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook – 2017 Edition, reveals several factors for the dose CMO industry’s relatively poor performance in 2016:

1. Rebound in drug development since 2013 is too recent to benefit dose CMOs

2. Heavy investment in captive capacity by global bio/pharma companies

3. Declining significance of dose manufacturing in drug cost of goods as new drugs with high value APIs dominate the pipeline

 


Save the date!

PBOA First Annual Meeting and Conference

October 3rd and 4th at the Bethesda North Marriott in Bethesda, MD

This event is open exclusively to PBOA-member companies!

Get the insider’s view on the regulatory, legislative and market trends driving the biopharmaceutical CDMO industry.

For details on the conference, visit www.pharma-bio.org/conference


PharmSource Strategic Advantage


Let PharmSource be your market intelligence guide.

PharmSource’s STRATEGIC ADVANTAGE service is the industry’s most respected outsourcing information web portal for serious consumers of information on contract drug development and manufacturing. Developed from PharmSource’s expert proprietary research, you won’t find this information in any other resource.

See for yourself how this resource gives you vital tools for understanding the industry.

To request a test-drive today, contact nathaniel@pharmsource.com / +1-703-383-4903, ext. 112.